MAJIC: A Phase III Prospective, Multicenter, Randomized, OpenLabel Trial of Acalabrutinib plus Venetoclax versus Venetoclax plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date22/11/22 → 21/11/27

Clinical Trial Phase

  • Phase III (a & b)